Abstract
Takotsubo cardiomyopathy (TC) is a condition most prevalent in postmenopausal women, characterized by transient left ventricular dysfunction following acute emotional or physical stress. Direct catecholamine-mediated myocyte injury and microvascular dysfunction leading to myocardial stunning are believed to play a major role in its pathogenesis. The treatment of TC remains empirical. In the acute phase, therapy must be individualized depending on hemodynamic situation. In stable conditions, it appears advantageous to prevent excessive sympathetic activation by combining alpha and beta blockade. Beta blockers are used to treat dynamic left ventricular obstruction. Phenylephrine may represent an alternative approach in patients presenting with outflow tract obstruction and severe hypotension. In hemodynamically unstable patients, early administration of intra-aortic balloon pump counterpulsation should be considered. As no consensus currently exists with respect to the chronic management of TC, randomized clinical trials are urgently needed with focus on treatment strategies.
Keywords: Takotsubo cardiomyopathy, transient left ventricular dysfunction, catecholamine-mediated injury, left ventricular outflow tract obstruction, beta blockers, Phenylephrine, hemodynamic situation, transient apical ballooning, broken heart, ampulla-syndrome, hypokinesis, akinesis, dyskinesis, cardiac troponin, pheochromocytoma, myocarditis, hypertrophic cardiomyopathy, dyspnoea, pulmonary oedema, cardiogenic shock, ventricular arrhythmias, hypovolemia, metaiodobenylguanidine, subarachnoid hemorrhage, Catecholamines, aspirin, heparin, ventriculography, intra-aortic balloon counterpulsation, Inotropes, coronary atherosclerosis
Current Pharmaceutical Design
Title: Treatment of Takotsubo Cardiomyopathy
Volume: 16 Issue: 26
Author(s): Tomas Palecek, Petr Kuchynka and Ales Linhart
Affiliation:
Keywords: Takotsubo cardiomyopathy, transient left ventricular dysfunction, catecholamine-mediated injury, left ventricular outflow tract obstruction, beta blockers, Phenylephrine, hemodynamic situation, transient apical ballooning, broken heart, ampulla-syndrome, hypokinesis, akinesis, dyskinesis, cardiac troponin, pheochromocytoma, myocarditis, hypertrophic cardiomyopathy, dyspnoea, pulmonary oedema, cardiogenic shock, ventricular arrhythmias, hypovolemia, metaiodobenylguanidine, subarachnoid hemorrhage, Catecholamines, aspirin, heparin, ventriculography, intra-aortic balloon counterpulsation, Inotropes, coronary atherosclerosis
Abstract: Takotsubo cardiomyopathy (TC) is a condition most prevalent in postmenopausal women, characterized by transient left ventricular dysfunction following acute emotional or physical stress. Direct catecholamine-mediated myocyte injury and microvascular dysfunction leading to myocardial stunning are believed to play a major role in its pathogenesis. The treatment of TC remains empirical. In the acute phase, therapy must be individualized depending on hemodynamic situation. In stable conditions, it appears advantageous to prevent excessive sympathetic activation by combining alpha and beta blockade. Beta blockers are used to treat dynamic left ventricular obstruction. Phenylephrine may represent an alternative approach in patients presenting with outflow tract obstruction and severe hypotension. In hemodynamically unstable patients, early administration of intra-aortic balloon pump counterpulsation should be considered. As no consensus currently exists with respect to the chronic management of TC, randomized clinical trials are urgently needed with focus on treatment strategies.
Export Options
About this article
Cite this article as:
Palecek Tomas, Kuchynka Petr and Linhart Ales, Treatment of Takotsubo Cardiomyopathy, Current Pharmaceutical Design 2010; 16 (26) . https://dx.doi.org/10.2174/138161210793176455
DOI https://dx.doi.org/10.2174/138161210793176455 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?
Current Medicinal Chemistry Immunologic Considerations in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews A Review of Patents Relating to Therapeutic Angiogenesis Using Endothelial Progenitors and Other Vasculogenesis-Related Cell Types
Recent Patents on Regenerative Medicine Isosteviol Protects H9c2 Cells Against Hypoxia-reoxygenation by Activating ERK1/2
Cardiovascular & Hematological Disorders-Drug Targets Antimicrobial Agents-Associated with QT Interval Prolongation
Current Drug Safety Adenosine Myocardial Perfusion Imaging
Current Medical Imaging Tomographic Imaging Methods and Gated Technique in Nuclear Cardiology: A Review on Current Status and Future Developments
Recent Patents on Medical Imaging Targeting the Arrhythmogenic Substrate in Atrial Fibrillation: Focus on Structural Remodeling
Current Drug Targets Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets MicroRNAs in Human Diseases
Recent Patents on DNA & Gene Sequences Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews Anti-infective and Antineoplastic Properties of Green Tea Catechins: Examining the Therapeutic Risk-benefit Ratio
Current Nutraceuticals Mitochondrial genome sequencing in atherosclerosis: what's next?
Current Pharmaceutical Design Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery Pleiotropic Effect of Statins as Antioxidants on Cardiac Hypertrophy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Role of iNOS in Chronic Inflammatory Processes In Vivo: Is it Damage-Promoting, Protective, or Active at all?
Current Molecular Medicine Metabolomics and Heart Diseases: From Basic to Clinical Approach
Current Medicinal Chemistry Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
CNS & Neurological Disorders - Drug Targets Long-circulating Targeted Nanoparticles for Cancer Therapy
Current Nanoscience A Comparative Summary on Antioxidant-like Actions of Timolol with Other Antioxidants in Diabetic Cardiomyopathy
Current Drug Delivery